These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)]. Glanzmann Ch; Horst W Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268 [TBL] [Abstract][Full Text] [Related]
24. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis. Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033 [No Abstract] [Full Text] [Related]
25. [Short-term results of treatment with 131I in patients with multinodular goiter: effect of the associated degree of hyperthyroidism and other variables]. Boj Carceller D; Liévano Segundo P; Navarro Beltrán P; Sanz París A; de Castro Hernández P; Monreal Villanueva M; Abós Olivares D Rev Esp Med Nucl; 2011; 30(3):156-61. PubMed ID: 21481495 [TBL] [Abstract][Full Text] [Related]
26. Hypothyroidism following 131I therapy for hyperthyroidism in relation to immunologic parameters. Lundell G; Holm LE Acta Radiol Oncol; 1980; 19(6):449-54. PubMed ID: 6263058 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
28. Hyperthyroidism and hypothyroidism complicating the treatment of thyrotoxicosis. Reid DJ Br J Surg; 1987 Nov; 74(11):1060-2. PubMed ID: 2446693 [TBL] [Abstract][Full Text] [Related]
29. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550 [TBL] [Abstract][Full Text] [Related]
30. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. Marcocci C; Gianchecchi D; Masini I; Golia F; Ceccarelli C; Bracci E; Fenzi GF; Pinchera A J Endocrinol Invest; 1990 Jun; 13(6):513-20. PubMed ID: 2258580 [TBL] [Abstract][Full Text] [Related]
32. Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong. Yau JS; Chu KS; Li JK; Chan KW; Lau IT; Yum SW; Chan CW; Mo LK; Kwan WK Hong Kong Med J; 2009 Aug; 15(4):267-73. PubMed ID: 19652233 [TBL] [Abstract][Full Text] [Related]
33. Transient hypothyroidism following radioiodine therapy for thyrotoxicosis. Connell JM; Hilditch TE; McCruden DC; Alexander WD Br J Radiol; 1983 May; 56(665):309-13. PubMed ID: 6850213 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Franklyn JA; Daykin J; Drolc Z; Farmer M; Sheppard MC Clin Endocrinol (Oxf); 1991 Jan; 34(1):71-6. PubMed ID: 2004475 [TBL] [Abstract][Full Text] [Related]
36. Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy. Connell JM; Hilditch TE; McCruden DC; Robertson J; Alexander WD Eur J Nucl Med; 1984; 9(10):464-6. PubMed ID: 6510423 [TBL] [Abstract][Full Text] [Related]